INTRODUCTION
Gastro-oesophageal reflux disease (GORD) in humans is characterised by pathological reflux of gastric or duodenal contents leading to regurgitation, retrosternal pain and oesophageal or supra-oesophageal complications. With impaired oesophageal sphincter function, oesophageal clearance mechanisms or mucosal resistance, reflux of gastric or duodenal contents including acid, pepsin, bile acids and trypsin can contribute to oesophageal damage (Boeckxstaens 2007 ) . It is thought that this disease also occurs in dogs because the clinical findings and response to treatment are similar to those reported in humans with GORD. In affected dogs, gastro-oesophageal reflux leads to inflammation, regurgitation and pain (Han 2003 ) , and characteristic refluxrelated oesophageal complications occur, including ulceration (Wilson 1977 ) , strictures (Bissett et al. 2009 ) and epithelial metaplasia (Gualtieri et al. 2008 , Gibson et al. 2010 . In addition, there may be respiratory complications such as laryngitis (Lux et al. 2012 ) , bronchial irritation and aspiration (Poncet et al. 2005 ) , and treatment with gastric acid suppressants can lead to resolution of clinical signs (Munster et al. 2013a ) .
GORD should therefore be considered in the list of differential diagnoses for dogs with clinical signs attributable to oesophageal disease and with obvious erosive mucosal lesions of the distal oesophagus detected by endoscopy. When other causes of oesophagitis, such as infection, chemical, toxic, caustic or foreign body injury or persistent vomiting can be ruled out, acid reflux is the most likely cause and antigastric acid treatment seems justified (Washabau 2013 ) . However, most dogs with clinical signs of oesophageal disease do not have obvious endoscopic mucosal lesions or other evidence of gastro-oesophageal reflux (Munster et al. 2015 ) . Regurgitation, ptyalism and signs of visceral pain may also occur with oropharyngeal disorders, extramural masses, vascular anomalies and functional oesophagopathies (e.g. megaoesophagus), hiatal hernia and gastrointestinal, biliary or pancreatic disorders (Kook 2014 ) . Until recently, specific diagnostic criteria for GORD in dogs were largely lacking and a tentative diagnosis was made if there were typical clinical signs and endo-scopic findings, other oesophageal and extra-oesophageal diseases could be ruled out and there was an adequate response to treatment (Han 2003 ) .
The approach to diagnosis of GORD has improved recently. Kook et al. ( 2014 ) evaluated gastro-oesophageal reflux in dogs with GORD using a telemetry device developed for humans. Changes in the squamous oesophageal epithelium caused by gastro-oesophageal reflux typically include papillary and basal cell hyperplasia, which have been demonstrated in dogs with experimental (Evander et al. 1987 , Van Nieuwenhove & Willems 1998 and spontaneous gastro-oesophageal reflux (Guilford & Strombeck 1996 ) . Analogous histological changes were consistently seen in cats (Geisinger et al. 1990 ) , rabbits (Lanas et al. 1999 ) , rats (Souza et al. 2009 ) and mice (Prade et al. 2012 ) with experimentally induced gastro-oesophageal reflux.
In humans, histological changes associated with hyper-regeneratory oesophagopathy (HRO) are considered pathognomonic for GORD (Ismail-Beigi et al. 1970 , Elster 1972 , and HRO recently was shown to occur in dogs. HRO is characterised by hyperplastic thickening of the basal cell layer and abnormal elongation of stromal papillae of the lamina propria, both of which reflect excessive regeneration. However, these changes must be widespread in at least one tissue sample to support a diagnosis because up to 30% of oesophageal samples from dogs undergoing endoscopy for non-oesophageal issues have focal hyperregeneratory lesions. A diagnosis of HRO can be supported histomorphometrically; in a study of 65 dogs with clinical signs attributable to oesophageal disease, the sensitivity and specificity of histomorphometry for the diagnosis of HRO was 0·55 and 0·92, respectively (Munster et al. 2015 ) . Results gleaned from telemetry and histological findings considered characteristic of GORD currently are the strongest evidence for the occurrence of pathological reflux in dogs.
We conducted several preliminary studies aimed at refining the procedure for histological examination of the squamous oesophageal epithelium of dogs. Although contrary to the opinion of many clinicians, we showed that biopsy specimens suitable for histological examination can be collected from the canine oesophagus during routine endoscopy (Munster et al. 2012 ). In our initial study, only 40% of samples were adequate, but with increased experience using an improved endoscopic biopsy technique and by employing a pathology laboratory with expertise in processing oesophageal biopsy specimens, this percentage increased to more than 77% (Munster et al. 2013b ) . Our preliminary studies also aimed at validating the histological findings for diagnosing GORD. The histological and morphometric results of 197 oesophageal biopsy samples collected endoscopically from 94 dogs were used to analyse histological changes of the squamous oesophageal epithelium induced by reflux and to determine cut-off values using a receiver operatier characteristic (ROC) curve analysis (Munster et al. 2015 ) . These preliminary methodological studies contributed to the successful application of oesophageal biopsy collection during routine endoscopy used in the present case series.
The prevalence and clinical significance of GORD in dogs is unknown. Current textbook opinions vary from "undoubtedly under-diagnosed" (Washabau 2013 ) to "it is not clear if GORD also represents a relevant problem in small animals" (Kook 2014 ) . The aim of the present study was to describe dogs with GORD, which was diagnosed using clinical signs and endoscopic and histological findings and by ruling out other oesophageal disorders.
MATERIALS AND METHODS
A total of 2225 dogs were seen at our referral clinic for small animal internal medicine from January 2012 to December 2014. A computer search identified 209 dogs that had undergone endoscopy of the upper digestive tract. The medical records of those dogs were evaluated for regurgitation, ptyalism and behavioural changes suggesting visceral pain or discomfort, and 82 dogs suffering from these conditions were identified. Of the 82 dogs, 62 were excluded from the study because they had no histological changes in the oesophageal epithelium (n=46), had histological changes not consistent with reflux (n=8) or they had histological changes consistent with reflux considered secondary to persistent vomiting, megaoesophagus, stricture formation as a result of anaesthesia or oesophageal dysfunction associated with polyneuropathy (n=8). Finally, 20 dogs were included in the study because HRO, which is considered pathognomonic for gastro-oesophageal reflux, was diagnosed in oesophageal biopsy specimens collected by endoscopy, and other oesophageal diseases and secondary causes of gastro-oesophageal reflux were ruled out. Furthermore, these 20 dogs had no history of gastric retention/dilation, recent anaesthesia, recent oral administration of doxycycline or clindamycin, potassium-containing pills, powdered pancreatic enzyme products, non steroidal antiinflammatory drugs (NSAIDs) or chemotherapeutic agents.
At the time of initial presentation, signalment and history were obtained from a questionnaire completed by the owner (Munster et al. 2015 ) , and all 20 dogs underwent clinical examination. Body condition score was assessed subjectively using a scale from 1 to 5 (1 emaciated, 3 ideal, 5 obese) and weight loss was determined by comparing the body condition of the dogs with ideal body condition. Biochemical and haematological blood analysis, parasitological examination of a faecal sample and radiography of the thorax were carried out in all dogs. In addition, 10 of 20 dogs underwent static contrast studies of the oesophagus. Abdominal ultrasonography was performed in 12 of 20 dogs with suspected abdominal disease. Using an endoscope, biopsy specimens were collected from the cardia, the body of the stomach, the pyloric antrum, the duodenum, the ventral and dorsal aspects of the gastro-oesophageal junction and the distal oesophagus. The specimens were fixed and processed routinely, and 4 µm tissue sections were stained with H&E for histological and morphometric analysis. The total thickness of the epithelium, the thickness of the basal cell layer and the length of the stromal papillae were measured using a validated software programme for microscopic morphometry (Cell D®, Olympus Europe Medical) at ×10 to ×40 magnification and expressed in micrometers. The pathologist was not blinded to the clinical and endoscopic findings. The upper margin of the basal cell layer was defined as the level below which 50% of nuclei were separated from each other by a distance measuring less than the diameter of one nucleus. If possible, tangent tissue sections and areas close to a papilla were not used for measurements. The length of a papilla was defined as the distance between an imaginary line drawn across the base of the papilla and the upper margin of the capillary furthest from the base (Fig 1 ) . A diagnosis of HRO was made when the thickness of the basal cell layer was greater than 20% of the total epithelial thickness and the length of the papillae greater than 60% of the total epithelial thickness in at least one tissue sample provided that these changes were widespread rather than focal (Fig 2 ) . The diagnosis was supported by histomorphometrical measurements and the measurements obtained from sections most severely affected by hyperplasia were reported; a basal cell layer thicker than 20 µm, stromal papillae longer than 65 µm and a total epithelial thickness greater than 154 µm are considered diagnostic for HRO (Munster et al. 2015 ) . Morpho-FIG 1 . Histological section of squamous oesophageal epithelium of a dog without hyper-regeneratory changes. The basal cell layer (***) constitutes less than 20% of the total epithelial thickness (*). The length of the stromal papillae of the lamina propria (**) is less than 60% of the total epithelial thickness (H&E. ×40) FIG 2 . Histological section of the squamous oesophageal epithelium of a dog with gastro-oesophageal reflux disease ( GORD ): the basal cell layer (***) constitutes more than 20% of the total epithelial thickness (*), the length of stromal papillae (**) exceeds 60% of the total epithelial thickness. The histological diagnosis was hyper-regeneratory oesophagopathy (H&E. ×20) metric measurements from biopsy sections without histological changes obtained from 19 client-owned control dogs were used for comparison. These dogs underwent endoscopy as part of the investigation of an extra-oesophageal disorder (e.g. chronic diarrhoea), and oesophageal biopsies had been obtained to exclude subclinical oesophagopathy. Eleven of the dogs with GORD were treated and clinically re-evaluated at the referral clinic 3 to 6 weeks after the start of treatment. The remaining nine dogs were treated and followed up at their primary care veterinary clinics.
The study was performed using 20 dogs with GORD and 19 clinical control dogs. Qualitative data including gender, clinical signs, clinical diagnoses and endoscopic and histological findings were presented descriptively. Quantitative data were tested for normality using the Kolmogorov-Smirnov test. Distribution of age, bodyweight and morphometric measurements of the thickness of the different layers of the squamous oesophageal epithelium was normal and means and standard deviations were reported for these variables. Drug dosage was not normally distributed and median and range were reported for this variable. Differences in morphometric measurements between dogs with GORD and clinical controls were analysed using analysis of variance (ANOVA), differences in the frequency of hyperplastic changes were analysed using Fisher ' s exact test and differences in the frequency of clinical signs before and after treatment were analysed using the McNemar ' s χ 2 test. Differences were considered statistically significant at P<0·05 for all analyses. A statistical software was used for analysis (Winstat® for Excel 2007.1).
RESULTS
Of the 20 dogs with GORD, body condition was 3 out of 5 in 11, 2 out of 5 in five and 4 out of 5 in four dogs. Five dogs belonged to brachycephalic breeds (Table 1 ). Based on the overall case load of 2225 dogs, the 3-year incidence of GORD was 0·9%, whereas the incidence of megaoesophagus was 0·4% (8 of 2225 dogs). In the dogs with GORD, clinical signs of painful oesophageal dysfunction were commonly reported by the owners (Table 2 ) and most signs were recurring. Of the 10 dogs with GORD that underwent oesophageal contrast studies, five had normal findings and five had prolonged retention of small amounts of contrast material. Persistent segmental or generalised oesophageal dilation was ruled out in all 10 dogs. Oesophagoscopy showed no (5/20 dogs) or minimal lesions (13/20 dogs) in the mucosa (Table 3 ; Figs 3 and 4 ) . Histological evaluation of the squamous oesophageal epithelium showed that the thickness of the basal cell layer, the length of stromal papillae of the lamina propria and the total thickness of the epithelium differed significantly between dogs with GORD and the clinical controls (Table 4 ) . Typical abnormal histological findings (Figs 2 and 5 ) including hyperplasia of the basal cell layer (thickness >20·0 µm, range 21·0 to 119·0 µm; 13/20 dogs), elongation of the stromal papillae (length >65 µm, range 73·0 to 340·0 µm; 14/20 dogs) and overall epithelial hyperplasia (thickness >154·0 µm, range 157·0 to 564·0 µm; 9/20 dogs) were significantly (P<0·00001, GORD Gastro-oesophageal reflux disease P<0·00005, P<0·001, respectively) more common in dogs with GORD than in control dogs (0/19 dogs, 1/19 dogs, 0/19 dogs, respectively). Capillary ectasia of stromal papillae (Fig 6 ) and pseudoepitheliomatous hyperplasia (Fig 7 ) (one dog each) were additional histological changes of the squamous oesophageal epithelium. There were sporadic increases in mononuclear cell infiltration of the squamous oesophageal epithelium (not quantified). Intraepithelial neutrophils and eosinophilic infiltration were not observed, and none of the dogs had active oesophagitis. Erosions, ulcers and intestinal metaplasia (Barrett ' s oesophagus) (Gibson et al. 2010 ) were not observed. Gastrointestinal comorbidity of GORD included mild to moderate lymphocytic (10/20 dogs) and severe chronic atrophic (1/20 dogs) gastritis, moderate lymphocytic duodenitis (1/20 dogs), Giardia species (3/20 dogs) and hookworm infestation (1/20 dogs) and a small gastric foreign body (2/20 dogs). The 11 dogs treated at our clinic received a proton pump inhibitor (PPI; omeprazole or pantoprazole; median dose, 1·5 mg/kg/day, range 1·0 to 2·0 mg/ kg/day) divided into two daily doses. Five of these dogs were fed home-prepared diets (one protein and one carbohydrate source) and six received commercial diets, and six of 11 dogs were fed in an upright body position. Additionally, four of 11 dogs received sucralfate twice daily (median dose, 1·0 g/dog/day; range, 1·0 to 2·0 g/dog/day) and three of 11 dogs received metoclopramide three times daily (median dose, 0·2 mg/kg/day; range, 0·15 to 0·3 mg/kg/day) for the first two weeks of treatment. One dog then discontinued. Six dogs were lost to follow-up, and clinical signs returned in four of the remaining five dogs over the following 12 to 54 weeks (median, 16 weeks) after discontinuation of treatment, necessitating resumption of treatment with a PPI. One dog underwent dietary changes and had complete remission of clinical signs after 16 weeks. with marked chronic atrophic gastritis and hiatal hernia was euthanased after four weeks because of persistence of clinical signs and poor prognosis. Clinical signs of regurgitation, ptyalism and discomfort/pain resolved completely in eight of 11 dogs, eight of 11 dogs and six of 11 dogs, respectively, 3-to 6-week after the start of treatment. In the dogs that responded favourably to treatment, the daily dose of PPI was reduced by half and given once a day for a further 1 to 2 weeks to reduce the potential risk of rebound acid hypersecretion. Treatment was 
DISCUSSION
The purpose of our study was to describe dogs with GORD and to estimate the clinical relevance of this disease. GORD was diagnosed in 0·9% of dogs presented to our referral clinic for internal medicine during a 3-year period. GORD occurred twice as frequently as megoesophagus, which had an incidence of 0·4%. These findings support previous suggestions that the incidence of canine GORD is underestimated (Washabau 2013 ) . GORD was associated with brachycephalic airway syndrome (Poncet et al. 2005 ) in five dogs, with hiatal hernia (Poncet et al. 2005 ) in two, and in 11 of 20 dogs, there was concurrent gastritis. All dogs had clinical signs of painful reflux, suggesting oesophageal dysfunction, and it can be assumed that gastro-oesophageal reflux was responsible for regurgitation associated with pain or discomfort and ptyalism since secondary causes of oesophageal dysfunction were ruled out in this population of dogs (Han 2003 ) . However, in contrast to humans, in which symptoms such as "heartburn" and acid eructation are considered indicative of gastro-oesophageal reflux, clinical signs of GORD are less specific in dogs; only 20 to 25% of dogs with clinical signs suggesting gastro-oesophageal reflux had GORD , Munster et al. 2015 . This means that a diagnosis of GORD should be based on more reliable criteria such as telemetric pH measurement or histological evaluation of oesophageal samples.
Even though digital high-resolution video endoscopy was used, 18 of the 20 dogs with signs suggestive of gastro-oesophageal reflux had no or only minimal mucosal lesions seen in the distal oesophagus and at the gastro-oesophageal junction. This finding was similar to reports in humans with GORD, in which 70% had no endoscopic lesions (Tytgat 2012 ) . Mild lesions seen in the present study consisted of abnormal vascular patterns including dilated capillaries and longitudinal red striations in more than half of the minimally affected dogs (Fig 3 ) . Capillary ectasia was seen in histological sections of elongated stromal papillae (Fig 6 ) possibly because reflux-induced elongation of the papillae displaced intrapapillary capillaries toward the surface making them more conspicuous. This suggests that red striations of the oesophageal mucosa (Vieth et al. 2001 ) seen endoscopically in dogs supports a diagnosis of GORD. Histological examination of specimens collected from the middle or distal section of an oesophagus with brown or red focal lesions, which we originally and erroneously assumed to be erosions, almost never showed haemorrhage or erosive lesions (Fig 4 ) . These focal lesions were interpreted as openings of the secretory ducts of submucosal oesophageal glands that had proliferated because of gastro-oesophageal reflux (Van Nieuwenhove & Willems 1998 ) and must not be confused with mucosal defects seen with erosive oesophagitis. Histological changes indicating advanced epithelial defects such as pseudoepitheliomatous hyperplasia of the basal cell layer (Vieth et al. 2013 ) were uncommon (Fig 7 ) . Our observations therefore suggest that erosive oesophagitis with mucosal defects endoscopically apparent as epithelial defects with a typical yellow margin and always accompanied by histological evidence of erosion or ulcer (Fiocca et al. 2010 ) is rare in dogs with GORD. It is therefore possible that in dogs, so-called "non-erosive reflux disease" (NERD) (Kiesslich et al. 2004 ) is more common than erosive or ulcerative oesophagitis. Because of a lack of obvious mucosal defects, it is not surprising that the diagnostic sensitivity of endoscopy is low in canine GORD (Munster et al. 2015 ) .
Hyperplastic changes such as abnormal elongation of stromal papillae and basal cell hyperplasia (Figs 2 and 5 ) are considered pathognomonic for GORD in humans (Elster 1972 , Ismail-Beigi et al. 1970 and have been described in dogs with experimental (Evander et al. 1987 , Van Nieuwenhove & Willems 1998 and spontaneous reflux (Guilford & Strombeck 1996 ) and are associated with typical clinical and endoscopic findings that subside with acid suppression therapy (Munster et al. 2015 ) . Experimental and clinical data suggest that HRO in dogs results from pathological gastro-oesophageal reflux. We were able to rule out other possible mechanical or chemical causes of epithelial hyper-regeneration and hyperplasia including foreign body, persistent vomiting, recurrent gastro-oesophageal intussusception, large sliding hernia and chemical injuries of non-gastric origin (Kook 2014 ) . In our experience, histological evaluation of oesophageal biopsy specimens from dogs without endoscopic signs of oesophagitis is helpful in the diagnosis of GORD. It also aids in the exclusion of other uncommon oesophageal diseases such as eosinophilic or mycotic oesophagitis and in the differentiation of benign ulceration or stricture caused by scar tissue from malignant processes.
Most dogs with GORD responded favourably to treatment. Before the start of treatment, clinical signs were largely episodic, and some dogs had recurrence of clinical signs after discontinuation of PPI treatment. GORD in dogs may therefore be considered a chronic waxing and waning disease. In our study population of dogs with GORD, the prognosis was favourable because severe complications such as oesophageal ulceration, stricture formation and epithelial metaplasia were uncommon sequels of this condition, and treatment was largely effective.
Epithelial proliferation in the absence of endoscopic and histological evidence of erosions was commonly encountered in the present study. This was in contrast to a previous hypothesis that GORD results from a chemical injury at the luminal surface of the squamous epithelium and progresses through the epithelium and lamina propria into the submucosa, resulting in acid-induced death of surface cells and stimulation of a proliferative response in the basal cells (Ismail-Beigi et al. 1970 , Evander et al. 1987 . This view has recently been challenged. Experimentally, refluxed gastric juice does not directly damage the oesophageal mucosa but rather stimulates oesophageal epithelial cells to proliferate and to secrete chemokines such as interleukin-8 and interleukin-1beta. These in turn attract and activate immune cells that damage the mature squamous oesophageal epithelial cells. Thus, basal cell and papillary hyperplasia precede the development of surface erosions (Souza et al. 2009 ). This revised concept of the pathogenesis of GORD in dogs may provide some explanation for epithelial hyperplasia in the absence of erosions. However, it is not known why only a small proportion of dogs develop erosive oesophagitis and other complications. It seems that epithelial hyperplasia is less pronounced in dogs than in humans with GORD (Munster et al. 2015 ) . It is possible that the canine oesophageal mucosa is less exposed to acid during a reflux episode ) and indicators of advanced acid-induced epithelial injury, such as dilated intercellular spaces, and indicators of severe chronic acid exposure, such as Barrett ' s oesophagus, are uncommon in dogs.
It was difficult to interpret clinical signs suggestive of visceral pain in the absence of obvious oesophageal damage. In addition to visceral pain caused by direct contact of free nerve endings in disrupted epithelium with acid, spastic oesophageal contractions or visceral oesophageal hypersensitivity also may cause pain. With impaired mucosal barrier function leading to acid diffusion through the oesophageal epithelium, oesophageal hypersensitivity may result from direct activation of pain receptors in the absence of erosions (Barlow & Orlando 2005 ) . Acid induces the overexpression of receptors, such as transient receptor potential vanilloid 1, which cause production and release of chemo-and cytokines; these in turn attract and activate immune cells that may contribute to oesophageal inflammation (Ma et al. 2010 ) . Oesophageal hypersensitivity could therefore explain visceral pain suffered by dogs that have reflux disease but no oesophageal injury, analogous to human patients with heartburn and NERD (Altomare et al. 2013 ) . However, this concept has not been confirmed in humans or dogs.
This study had several limitations. The correlation between the degree of histological changes and severity of reflux could not be examined because oesophageal pH measurements were not performed. Histological changes of squamous oesophageal epithelium were not graded, primarily because such a grading system does not exist for dogs. Although clinical signs improved with treatment, we were unable to determine whether the histological changes receded in parallel because a second endoscopic examination of client-owned dogs did not appear reasonable. A clinically-relevant disease may be defined as a process that conflicts with health, is characterised by an abnormal manifestation of life and is associated with pathological changes of body tissues (Schulz 1982 ) . The results of the present study agree with this general definition and support the hypothesis that canine GORD is a clinically-relevant disorder.
We conclude that, based on our data, canine GORD appears to be under-diagnosed in small animal medicine. In dogs with clinical signs of painful oesophageal dysfunction, the diagnosis of GORD is facilitated by endoscopic biopsy and histological evaluation of the oesophageal epithelium.
